Skip to content
HowShorted

Diebold Nixdorf, Incorporated short interest in 2023

In 2023, Diebold Nixdorf, Incorporated's disclosed short interest ran from 12.21% of shares outstanding on 13 Jan 2023 to 0.42% on 15 Dec 2023, a change of -11.79 percentage points. The year's high was 22.83% on 31 May 2023 and its low 0.21% on 31 Oct 2023, averaging 10.81% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.20 days on 13 Jan 2023. Full history: Diebold Nixdorf, Incorporated.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Diebold Nixdorf, Incorporated in 2023

2023 in figures

Start of year
12.21% (13 Jan 2023)
End of year
0.42% (15 Dec 2023)
Change
-11.79 pp
High
22.83% (31 May 2023)
Low
0.21% (31 Oct 2023)
Average
10.81%
Highest days to cover
12.20 (13 Jan 2023)
SEC filings marked
8

Every report in 2023

Diebold Nixdorf, Incorporated short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202312.21%12.20
31 Jan 202311.95%6.54
15 Feb 202310.92%3.56results (8-K)
28 Feb 202310.48%6.09
15 Mar 202310.82%4.82
31 Mar 202318.35%1.5510-K filed
14 Apr 202319.77%5.56
28 Apr 202321.13%9.81
15 May 202322.27%4.38results (8-K)
31 May 202322.83%9.0710-Q filed
13 Oct 20230.23%3.1910-Q filed, results (8-K)
31 Oct 20230.21%4.85
15 Nov 20230.32%1.2910-Q filed, results (8-K)
30 Nov 20230.25%1.04
15 Dec 20230.42%1.00

See also: Diebold Nixdorf, Incorporated's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.